$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the efficacy of Shafinamide Tablets (Siddaco) and its clinical efficacy in Parkinson’s patients
2026-02-01 22:25:32
Check Details
Tarlatamab-Imdelltra official instructions and instructions for use
2026-02-01 22:25:32
Check Details
Analysis of whether telisotuzumab-EMRELIS has been included in medical insurance and reimbursement policies and conditions
2026-02-01 22:25:32
Check Details
Tovorafenib tablets are suitable for different age groups and different patient dosage regimens and clinical guidelines.
2026-02-01 22:25:32
Check Details
Vorasidenib-VORANIGO market price and drug purchase reference instructions
2026-02-01 22:25:32
Check Details
Summary and analysis of Zongertinib clinical trial data and drug resistance
2026-02-01 22:25:32
Check Details
Vosoritide 2025 price list and market reference cost details
2026-02-01 22:25:32
Check Details
Possible adverse reactions of Pemetinib/Dabotan
2026-02-01 22:25:32
Check Details
Will tumors grow wildly after stopping the targeted drug Erdafitinib/Bocco?
2026-02-01 22:25:32
Check Details
Recommendations on the best time to take dacomitinib/dacomitinib (Dozerun) in a day
2026-02-01 22:25:32
Check Details
The mechanism of action and anti-tumor principle of brigatinib/brigatinib (Embry)
2026-02-01 22:25:32
Check Details
Where can I buy Entrectinib in the country?
2026-02-01 22:25:32
Check Details
1
2
...
2275
2276
2277
2278
2279
2280
2281
...
10228
10229
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
2
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor
3
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
4
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
5
Nintedanib: A Multi-Target Antifibrotic Agent for Slowing Pulmonary Fibrosis Progression
6
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
7
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
8
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
9
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
10
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
11
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
12
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments